Targeted therapies trang 1 tải miễn phí từ TAILIEUCHUNG

"Targeted therapies" trang 1 - tải miễn phí từ Tailieuchung

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies

Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies

7 48 1

Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies

Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies

9 54 2

Case report: Whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies

Case report: Whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies

10 39 1

Off-label use of targeted therapies in osteosarcomas: Data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)

Off-label use of targeted therapies in osteosarcomas: Data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)

9 27 1

DISORDERS and DISEASES: Cancer

DISORDERS and DISEASES: Cancer

105 40 0

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

9 73 1

Establishment of patient-derived gastric cancer xenografts: A useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways

Establishment of patient-derived gastric cancer xenografts: A useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways

11 41 1

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer: The protect-2 study

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer: The protect-2 study

10 47 1

Highly sensitive detection of the PIK3CAH1047R mutation in colorectal cancer using a novel PCR-RFLP method

Highly sensitive detection of the PIK3CAH1047R mutation in colorectal cancer using a novel PCR-RFLP method

11 54 1

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry

11 32 1

The off-label use of targeted therapies in sarcomas: The OUTC’S program

The off-label use of targeted therapies in sarcomas: The OUTC’S program

11 33 1

Network meta-analysis of targeted therapies for diffuse large B cell lymphoma

Network meta-analysis of targeted therapies for diffuse large B cell lymphoma

10 21 1

How are we evaluating the costeffectiveness of companion biomarkers for targeted cancer therapies? A systematic review

How are we evaluating the costeffectiveness of companion biomarkers for targeted cancer therapies? A systematic review

21 25 1

Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma

Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma

10 58 0

Báo cáo y học: "γ Activating and inhibitory Fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies"

2 25 0

báo cáo khoa học:

báo cáo khoa học: "Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy"

9 88 0

Ebook Personalized treatment options in dermatology (E): Part 1

Ebook Personalized treatment options in dermatology (E): Part 1

79 52 0

New trends in the therapeutic approach to metastatic colorectal cancer

New trends in the therapeutic approach to metastatic colorectal cancer

7 38 0

Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: A systematic review and secondary analysis of trials

Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: A systematic review and secondary analysis of trials

17 72 0

Tumor cell sensitivity to vemurafenib can be predicted from protein expression in a BRAF-V600E basket trial setting

Tumor cell sensitivity to vemurafenib can be predicted from protein expression in a BRAF-V600E basket trial setting

13 46 0

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.